Results for tag: "Polycythemia"

Polycythemia is a hematological disorder characterized by an increase in the number of red blood cells in the body. It is caused by an overproduction of red blood cells by the bone marrow, which can lead to an increase in the viscosity of the blood. Symptoms of polycythemia include fatigue, dizziness, headaches, and shortness of breath. Treatment options for polycythemia include phlebotomy, hydroxyurea, and interferon therapy. The polycythemia market is a subset of the hematology market, which is estimated to be worth billions of dollars. The polycythemia market is expected to grow due to the increasing prevalence of the disorder and the development of new treatments. Companies in the polycythemia market include Novartis, Pfizer, Amgen, and Bristol-Myers Squibb. Show Less Read more